Hong Kong stock market anomaly | Jiangxi biology (06915.HK) rose more than 17% to a new high in recent months, and its wholly-owned subsidiary recently received the approval document for the tetanus antitoxin for veterinary use.

According to the Zhitong Finance and Economics APP, Jiangxi Bio (06915.HK) rose by more than 17%, with the stock price reaching a high of 12.11 Hong Kong dollars in intraday trading, setting a new record high. As of the time of writing, it has risen by 17.1% to 12.05 Hong Kong dollars, with a trading volume of 39.06 million Hong Kong dollars.